Butterfly Network (BFLY) Non-Current Deffered Revenue (2020 - 2026)
Butterfly Network (BFLY) posted Non-Current Deffered Revenue of $10.2 million for Q2 2026, up 5.75% sequentially from $9.6 million in Q1 2026, and up 40.85% YoY from $7.2 million in Q2 2025.
Butterfly Network (BFLY) Non-Current Deffered Revenue (2020 - 2026) Analysis & Trends
Butterfly Network has reported Non-Current Deffered Revenue for 7 years, with the latest figure at $10.2 million in Q2 2026.
- Quarterly Non-Current Deffered Revenue rose 40.85% year-over-year to $10.2 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $10.2 million (up 40.85% YoY) and the FY2025 annual result came in at $9.4 million, up 28.38% from the prior year.
- Non-Current Deffered Revenue climbed to $10.2 million in Q2 2026 per BFLY's latest filing, from $9.6 million in the prior quarter.
- Over five years, Non-Current Deffered Revenue peaked at $10.2 million in Q2 2026 and troughed at $4.3 million in Q1 2023.
- A 5-year average of $7.1 million and a median of $7.2 million in 2024 frame the typical range for Non-Current Deffered Revenue.
- The sharpest annual moves came in 2023 and 2024: Non-Current Deffered Revenue tumbled 30.74% in 2023, then soared 66.14% in 2024.
- Over 5 years, Non-Current Deffered Revenue stood at $5.0 million in 2022, then soared by 49.16% to $7.4 million in 2023, then fell by 1.07% to $7.3 million in 2024, then grew by 28.38% to $9.4 million in 2025, then advanced by 8.45% to $10.2 million in 2026.
- According to Business Quant data, Non-Current Deffered Revenue over the past three periods registered $10.2 million, $9.6 million, and $9.4 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | - |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | - |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | - |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 539.34 Mn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | - |
| 10 | Butterfly Network | 2.41 Bn | 2.28 Bn | 23.29 Mn | 10.19 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 10.19 Mn |
| Mar 31, 2026 | 9.63 Mn |
| Dec 31, 2025 | 9.39 Mn |
| Sep 30, 2025 | 7.91 Mn |
| Jun 30, 2025 | 7.23 Mn |
| Mar 31, 2025 | 7.60 Mn |
| Dec 31, 2024 | 7.32 Mn |
| Sep 30, 2024 | 7.04 Mn |
| Jun 30, 2024 | 7.36 Mn |
| Mar 31, 2024 | 7.22 Mn |
| Dec 31, 2023 | 7.39 Mn |
| Sep 30, 2023 | 5.27 Mn |
| Jun 30, 2023 | 6.03 Mn |
| Mar 31, 2023 | 4.34 Mn |
| Dec 31, 2022 | 4.96 Mn |
| Sep 30, 2022 | 5.59 Mn |
| Jun 30, 2022 | 6.95 Mn |
| Mar 31, 2022 | 6.27 Mn |
| Dec 31, 2021 | 5.48 Mn |
| Sep 30, 2021 | 4.88 Mn |